Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine A High

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
Blood|July 26, 2012
The gene therapy journey for hemophilia: are we there yet?Katherine A High
Nature Medicine|August 2, 2003
Coaxing coagulation with RNA and cell fragmentsKatherine A High
The Hastings Center Report|May 23, 2003
The risks of germline gene transferKatherine A High
Seminars in Thrombosis and Hemostasis|May 1, 2004
Clinical gene transfer studies for hemophilia BKatherine A High
Nature Communications|November 17, 2020
Turning genes into medicines-what have we learned from gene therapy drug development in the past decade?Katherine A High
Human Gene Therapy|November 15, 2014
Gene therapy for hemophilia: the clot thickensKatherine A High
Transactions of the American Clinical and Climatological Association|September 13, 2023
THE JEREMIAH METZGER LECTURE: TURNING GENES INTO MEDICINES: HIGHLIGHTS AND HURDLES IN THE DEVELOPMENT OF GENE THERAPY FOR GENETIC DISEASEKatherine A High
The Journal of Clinical Investigation|July 11, 2006
The leak stops here: platelets as delivery vehicles for coagulation factorsKatherine A High
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2011
rAAV human trial experienceKatherine A High, Patrick Aubourg
Current Gene Therapy|May 12, 2011
Immune responses to AAV in clinical trialsFederico Mingozzi, Katherine A High
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
Blood|July 26, 2012
The gene therapy journey for hemophilia: are we there yet?Katherine A High
Nature Medicine|August 2, 2003
Coaxing coagulation with RNA and cell fragmentsKatherine A High
The Hastings Center Report|May 23, 2003
The risks of germline gene transferKatherine A High
Seminars in Thrombosis and Hemostasis|May 1, 2004
Clinical gene transfer studies for hemophilia BKatherine A High
Nature Communications|November 17, 2020
Turning genes into medicines-what have we learned from gene therapy drug development in the past decade?Katherine A High
Human Gene Therapy|November 15, 2014
Gene therapy for hemophilia: the clot thickensKatherine A High
Transactions of the American Clinical and Climatological Association|September 13, 2023
THE JEREMIAH METZGER LECTURE: TURNING GENES INTO MEDICINES: HIGHLIGHTS AND HURDLES IN THE DEVELOPMENT OF GENE THERAPY FOR GENETIC DISEASEKatherine A High
The Journal of Clinical Investigation|July 11, 2006
The leak stops here: platelets as delivery vehicles for coagulation factorsKatherine A High
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2011
rAAV human trial experienceKatherine A High, Patrick Aubourg
Current Gene Therapy|May 12, 2011
Immune responses to AAV in clinical trialsFederico Mingozzi, Katherine A High
Pageof 16